Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $13.3M | $15.5M | $21.6M | $28.7M | $19.5M | $22.2M | $21.0M |
| Revenue growth | — | 16.6% | 39.6% | 33.3% | -32.2% | 13.9% | -5.7% |
| Gross profit | $19.1M | $23.4M | $30.2M | $39.2M | $36.5M | $31.5M | $26.8M |
| Gross margin | 144.2% | 151.5% | 140.2% | 136.2% | 187.4% | 141.9% | 127.9% |
| Operating income | -$12.4M | -$11.1M | -$18.2M | -$27.4M | -$48.3M | -$51.2M | -$51.9M |
| Operating margin | -93.7% | -71.6% | -84.3% | -95.2% | -247.7% | -230.5% | -247.6% |
| Net income | -$12.9M | -$11.8M | -$19.1M | -$23.6M | -$37.9M | -$41.1M | -$44.6M |
| Net margin | -97.3% | -76.5% | -88.5% | -82.0% | -194.5% | -184.8% | -213.0% |
| EPS (diluted) | -$0.23 | -$0.17 | -$0.21 | -$0.23 | -$0.37 | -$0.39 | -$0.42 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.80M | -$8.78M | -$10.7M | -$14.8M | -$21.7M | -$27.6M | -$34.4M |
| Capital expenditures | $1.27M | $2.07M | $3.83M | $18.5M | $3.70M | $1.65M | $1.77M |
| Free cash flow | -$10.1M | -$10.9M | -$14.5M | -$33.3M | -$25.4M | -$29.3M | -$36.2M |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15.2M | $18.8M | $47.8M | $11.1M | $46.5M | $27.9M | $20.1M |
| Total assets | — | $51.8M | $284M | $287M | $268M | $239M | $203M |
| Total liabilities | — | $18.6M | $21.2M | $32.7M | $36.1M | $33.2M | $31.0M |
| Shareholders' equity | $13.6M | $33.2M | $263M | $254M | $232M | $206M | $171M |
| Retained earnings | — | -$95.2M | -$114M | -$138M | -$176M | -$217M | -$261M |
| Shares (wtd avg diluted) | 56.4M | 69.5M | 90.6M | 102M | 103M | 105M | 106M |
Every figure is extracted from MAXCYTE, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.